Weekly Recap

IPO Weekly Recap 6.19.2015 — FitBit paces strong week of IPOs

This past week seven IPOs priced, fourteen updated terms and fourteen new deals were filed. (click to expand) It was a strong week for IPOs with a number of deals increasing their respective size and/or pricing above their range. Both of those instances occurred in this week’s strongest deal, FitBit (NYSE: FIT). ‘FIT’ priced ($20.00)[…]

IPO Weekly Recap 5.1.2015 – Tough Sledding for New Issues

This past week four IPOs debuted, eleven updated terms and two new deals filed. It was tough sledding for the four deals that debuted. The strongest deal of the week, BluePrint Medicines Corporation (Nasdaq: BPMC), upsized and priced ($18.00) above range. ‘BPMC’ opened 30-percent higher with a $23.40 tick at first trade. However, BluePrint traded[…]

IPO Weekly Recap: Apigee sells off in opening day

This past week two IPOs debuted, seven updated terms and six new deals filed. The deal of the week, Apigee Corporation (Nasdaq: APIC), was many-multiple times oversubscribed and priced ($17.00) at the mid-point of the $16-$18 range. ‘APIC’ opened with a three-dollar premium with a $20.00 first trade; however, the deal sold off on day[…]

IPO Weekly Recap: 4.10.2015 – Carbylan opens higher

This past week two IPOs debuted, six updated terms and seven new deals filed. It was a very quiet week on the IPO front as just two deals debuted. After a lengthy delay and amended terms Carbylan Therapeutics (Nasdaq: CBYL) priced an up-sized offering at $5.00. The deal opened 30% higher with a first trade[…]

IPO Weekly Recap 3.20.2015 & look ahead

This past week two IPOs debuted, two updated terms and four new deals filed. Two of the three deals this week opened below their respective offering prices. The deal that worked, National Commerce Corporation (NYSE: NCOM) was just a 1.7 million share offering. ‘NCOM’ priced mid-range, $19.50, and opened 8% higher with a $21.05 first[…]

Weekly IPO Recap: 2.21.2015

This past week two IPOs debuted, zero updated terms and six new deals filed. It was week that produced very little fanfare as the deals that came to market, Inotek Pharmaceuticals (Nasdaq: ITEK) and Check-Cap Limited (Nasdaq: CHEKU) were holdovers from the previous week. Inotek was able to come to market after severely slashing their[…]

Scroll to top
error: Content is protected !!